Diabetes Mellitus: could the Inhibition of a Single Enzyme (CPT-1) Involved in the Beta-Oxidation Process Improve this Complex Disease?-Current Research in Diabetes & Obesity Journal-Juniper Publishers
JUNIPER PUBLISHERS-CURRENT RESEARCH IN DIABETES &
OBESITY JOURNAL
DIABETES
MELLITUS: COULD THE INHIBITION OF A SINGLE ENZYME (CPT-1) INVOLVED IN THE
BETA-OXIDATION PROCESS IMPROVE THIS COMPLEX DISEASE?
Authored by Piero Chiodi
Diabetes mellitus is a heterogeneous chronic disease
characterized by hyperglycemia, and insulin resistance. The causes lie
the interaction of genetic and environmental factors that occur with
deficiency in production of insulin by the pancreas, or by
ineffectiveness of insulin produced.
Diabetes mellitus is among ten leading cause of death
in high-income countries and it is increasing rapidly in countries
undergoing industrialization. Diabetes alone claims on the average
around 8% of total health budgets in developed countries [1].
Complications include diabetic retinopathy, renal failure, heart
disease, diabetic neuropathy and foot ulceration and amputation. More
than 90% of diabetic patients in the United States are Type 2 diabetics,
or non-insulin-dependent diabetes mellitus (NIDDM). In NIDDM a severe
glycemic control should be made by a synergic work of physical activity,
diabetic diet, and the use of hypoglycemic agents, and lastly insulin.
For
Read More... Fulltext click in https://juniperpublishers.com/crdoj/CRDOJ.MS.ID.555563.php
For
More Articles in Current
Research in Diabetes & Obesity Journal Please Click on
For
More Open Access Journal In Juniper Publishers Please Click on: https://juniperpublishers.com/index.php
Comments
Post a Comment